AI Verdict
GAP has stronger fundamentals based on our AI analysis.
GAP vs GANX Fundamental Comparison
| Metric | GAP | GANX |
|---|---|---|
| Revenue | $15.4B | $305,239.0 |
| Net Income | $816.0M | $-15.6M |
| Net Margin | 5.3% | -5,118.5% |
| ROE | 21.5% | -264.4% |
| ROA | 6.5% | -142.4% |
| Current Ratio | 1.75x | 2.52x |
| Debt/Equity | 0.39x | 0.07x |
| EPS | $2.13 | $-0.50 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
GAP vs GANX: Frequently Asked Questions
Is GAP or GANX a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), GAP has stronger fundamentals. GAP is rated HOLD (72% confidence) while GANX is rated STRONG SELL (92% confidence). This is not investment advice.
How does GAP compare to GANX fundamentally?
GAP INC has ROE of 21.5% vs Gain Therapeutics, Inc.'s -264.4%. Net margins are 5.3% vs -5,118.5% respectively.
Which stock pays higher dividends, GAP or GANX?
GAP has a dividend yield of N/A or no dividend while GANX has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in GAP or GANX for long term?
For long-term investing, consider that GAP has HOLD rating with 72% confidence, while GANX has STRONG SELL rating with 92% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about GAP vs GANX?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For GAP vs GANX, the AI consensus favors GAP based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.